Keyword: Sun Pharmaceutical Industries
News
24.01.2023
-
Indian drugmaker Sun Pharmaceutical Industries is to buy US biotech Concert Pharmaceuticals, gaining access to the latter’s lead product candidate deuruxolitinib for...
News
09.04.2014
- Sun Pharmaceutical Industries, India's largest drugmaker by market value, has agreed to buy compatriot generics manufacturer Ranbaxy Laboratories for $3.2 billion from Daiichi...
News
07.04.2014
- Swedish generic drugmaker Meda has rejected a takeover approach by U.S. rival Mylan to create a combined company worth around $24 billion. Reports said Mylan was exploring a bid at...
News
12.06.2013
- Pfizer said Teva Pharmaceuticals Industries and Sun Pharmaceutical Industries would pay $2.15 billion to settle a patent suit related to its acid-reflux drug. This is the first...
News
13.08.2012
- India's Sun Pharmaceutical Industries has upped the buy-out price for its Israeli unit Taro Pharma by 60%, winning over Taro's board and ending a long battle to gain full control...
News
19.07.2012
- Pfizer beat back a challenge from generic drugmakers to a patent that protects its pain medicine Lyrica, its second-best selling drug when a federal judge ruled in its favor on...
News
18.04.2012
- The U.S. Supreme Court ruled on Tuesday in favor of a generic drugmaker in a case over how companies can fight brand-name rivals in an effort to get their cheaper medicines to...
News
27.04.2011
- Sun Pharmaceutical Industries has entered into a deal to market Merck & Co's diabetes drugs - sitagliptin and sitagliptin plus metformin - in India, the two drugmakers said in a...
